Jeffrey M. Lemons, MD, on Solid Tumors: Safety Data on SBRT and Immunotherapy

2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Tweet this page

Jeffrey M. Lemons, MD, of the University of Chicago, discusses early safety and efficacy findings from a small study on pembrolizumab and multiorgan-site ablative stereotactic body radiotherapy in patients with advanced solid tumors (Abstract 20).

Advertisement

Advertisement



Advertisement